Diana Mckenzie - Dec 14, 2023 Form 4 Insider Report for METLIFE INC (MET)

Role
Director
Signature
/s/ Anna Nazarenko, Authorized Signer
Stock symbol
MET
Transactions as of
Dec 14, 2023
Transactions value $
$8,831
Form type
4
Date filed
12/18/2023, 05:19 PM
Previous filing
Oct 17, 2023
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award $8.83K +132 +0.77% $66.90 17.2K Dec 14, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.